Clinical Trial Update: MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the association of MirvasO and Soolantra for treating moderate to severe rosacea; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Mirvaso (brimonidine tartrate)
• Soolantra (ivermectin)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2017-10-19